Putnam Investments’s Immunomedics Inc IMMU Stock Holding History

Putnam Investments’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-95,844	Closed	-$8.15M	–	903
2020 Q3	$8.15M	Sell	95,844 -40,427	-30%	-$2.04M	0.02%	374
2020 Q2	$4.83M	Sell	136,271 -1,213	-0.9%	-$35.5K	0.01%	470
2020 Q1	$1.85M	Sell	137,484 -880	-0.6%	-$14.8K	﹤0.01%	637
2019 Q4	$2.93M	Buy	+138,364	New	+$2.44M	0.01%	663
2018 Q1	–	Sell	-16,875	Closed	-$273K	–	1215
2017 Q4	$273K	Buy	+16,875	New	+$199K	﹤0.01%	1028

Putnam Investments's IMMU Position: Q4 2020 in Review

Putnam Investments sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 95,844 shares — an estimated $8.15M sold.

Putnam Investments first reported a position in IMMU in Q4 2017 and held it in 5 quarters. The position peaked at $8.15M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Putnam Investments reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Putnam Investments sold 95,844 Immunomedics Inc shares in Q4 2020, an estimated $8.15M.
Putnam Investments first reported a position in Immunomedics Inc in Q4 2017 and held it in 5 quarters.
Putnam Investments's Immunomedics Inc position peaked at $8.15M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Putnam Investments's 13F filing for Q4 2020, filed 16 Feb 2021.